The table below shows BIOMARIN PHARMACEUTICAL INC's cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q1 2025
Q1 2024
Q1 2023
Q1 2022
Q1 2021
Operating cash flow
$220.65M
$174.39M
$46.97M
-$73.93M
-$45.43M
$113.51M
Capital expenditure
$20.92M
$16.77M
$26.10M
$24.46M
$28.82M
$25.51M
Investing cash flow
$725.53M
-$28.24M
-$14.24M
-$30.01M
$87.78M
-$70.79M
Dividends paid
-
-
-
-
BMRN operating cash flow (10-K history)
BIOMARIN PHARMACEUTICAL INC reported operating cash flow of $827.99M for fiscal year 2025. That is up 44.5% from $572.84M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from -$227.84M (FY 2016) to $827.99M. Figures come from the company's audited annual reports as filed with the SEC.
